Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Tick-borne encephalitis vaccine - Hyland Immuno/Pfizer

Next Previous
X
Search
Drug Profile

Tick-borne encephalitis vaccine - Hyland Immuno/Pfizer

Alternative Names: FSME-IMMUN Junior; FSME-IMMUN NEW; FSME-IMMUNE; PF-06830414; TBE vaccine - Pfizer; TicoVac; TicoVac Junior

Latest Information Update: 03 Apr 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Hyland Immuno
  • Developer Hyland Immuno; Pfizer
  • Class Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Encephalitis virus infections

Most Recent Events

  • 26 Mar 2024 Registered for Encephalitis virus infections (In adolescents, In children, In the elderly, In infants, Prevention, In adults) in Japan (IM)
  • 21 Feb 2022 Pfizer completes a phase III trial in Encephalitis virus infections (In infants, In children, In adolescents, In adults, In the elderly, Prevention) in Japan (IM) (NCT04648241)
  • 13 Aug 2021 Registered for Encephalitis virus infections (In children, In infants, In adolescents, In adults, In the elderly, Prevention) in USA (IV)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top